A detailed history of Loomis Sayles & CO L P transactions in Pfizer Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 8,450 shares of PFE stock, worth $224,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,450
Previous 7,873 7.33%
Holding current value
$224,432
Previous $220,000 11.36%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $15,982 - $18,112
577 Added 7.33%
8,450 $245,000
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $934 - $1,095
-37 Reduced 0.47%
7,873 $220,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $3,391 - $3,894
-131 Reduced 1.63%
7,910 $220,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $18,682 - $24,267
-715 Reduced 8.17%
8,041 $232,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $350,968 - $410,246
-10,937 Reduced 55.54%
8,756 $290,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $30,701 - $35,521
-850 Reduced 4.14%
19,693 $722,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $229,761 - $299,116
-5,833 Reduced 22.11%
20,543 $838,000
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $450,774 - $588,436
10,797 Added 69.3%
26,376 $1.35 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $336,033 - $410,212
7,679 Added 97.2%
15,579 $682,000
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $858,664 - $1.02 Million
-18,454 Reduced 70.02%
7,900 $414,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $335,988 - $416,331
-7,344 Reduced 21.79%
26,354 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $290,190 - $430,158
-7,023 Reduced 17.25%
33,698 $1.99 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $185,220 - $237,931
-4,719 Reduced 10.39%
40,721 $1.75 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $117,425 - $133,023
3,270 Added 7.75%
45,440 $1.78 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $1.38 Million - $1.55 Million
41,094 Added 3819.14%
42,170 $1.53 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $180,503 - $229,526
-5,393 Reduced 83.37%
1,076 $40,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $54,292 - $63,697
-1,710 Reduced 20.91%
6,469 $237,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $366,108 - $444,143
-12,155 Reduced 59.78%
8,179 $267,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.18 Million - $1.68 Million
-43,563 Reduced 68.18%
20,334 $664,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.82 Million - $2.06 Million
55,191 Added 633.94%
63,897 $2.5 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $3.52 Million - $4.57 Million
-108,427 Reduced 92.57%
8,706 $313,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $4.33 Million - $4.86 Million
117,133 New
117,133 $5.07 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $272,062 - $298,906
-7,255 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $3.03 Million - $3.45 Million
-78,684 Reduced 91.56%
7,255 $317,000
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $9.84 Million - $11.9 Million
-285,435 Reduced 76.86%
85,939 $3.79 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $8.33 Million - $8.88 Million
-252,552 Reduced 40.48%
371,374 $13.5 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $37.2 Million - $43.1 Million
-1,165,140 Reduced 65.13%
623,926 $22.1 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $30 Million - $31.8 Million
-900,771 Reduced 33.49%
1,789,066 $64.8 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $8.88 Million - $9.78 Million
-286,422 Reduced 9.62%
2,689,837 $96 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,976,259
2,976,259 $100 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.